Multicenter phase II trial with 5-day continuous infusion of vindesine in metastatic malignant melanoma.

Mayol, X F

Multicenter phase II trial with 5-day continuous infusion of vindesine in metastatic malignant melanoma. [electronic resource] - Cancer treatment reports Sep 1984 - 1199-200 p. digital

Publication Type: Journal Article

0361-5960


Adult
Aged
Drug Administration Schedule
Drug Evaluation
Female
Humans
Infusions, Parenteral
Male
Melanoma--drug therapy
Middle Aged
Vinblastine--administration & dosage
Vindesine